NYSE:TMOLife Sciences
Thermo Fisher Scientific (TMO): Assessing Valuation Following Barclays Upgrade and CFO Succession Announcement
If you've been trying to figure out what to do with Thermo Fisher Scientific (TMO) lately, you're not alone. Barclays' recent upgrade of the stock has turned a few heads, especially coming on the heels of the company's announcement that its long-serving CFO will retire next March. The company already has a clear plan for succession in place. Together, these events have generated a wave of discussion about leadership, strategy, and what might lie ahead for TMO as the industry shifts and...